Results 91 to 100 of about 99,753 (275)

B-cell lymphoma showing typical features of angioimmunoblastic T-cell lymphoma [PDF]

open access: yes, 2008
We present a 52-year-old man who was diagnosed with B cell-derived angioimmunoblastic lymphoma. He was admitted with systemic, including mediastinal and para-aortic, lymphadenopathy, fever and skin itching.
Furukawa , Yusuke   +5 more
core  

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified [PDF]

open access: yes, 2014
Peripheral T-cell lymphomas not otherwise specified (PTCLs/NOS) are rare and aggressive tumours whose molecular pathogenesis and diagnosis are still challenging.
Agostinelli, C.   +22 more
core   +3 more sources

A Case of Angioimmunoblastic T-cell Lymphoma (AITL)

open access: yesJournal of UOEH, 2022
A 84-year-old female noticed erythema over her whole body for several months and was referred to our department for evaluation of her skin eruption. A physical examination revealed millet-sized erythematous papules and macules all over her body, a high body temperature, and a decreased level of consciousness. A laboratory examination showed an elevated
Ayaka, Kaneoka   +4 more
openaire   +2 more sources

Delineation of the Human Germinal Centre Immune Landscape Using Multiplex Imaging Analysis

open access: yesImmunology, EarlyView.
Human CD4 follicular helper T cells (TFH) are a heterogeneous cell population at the phenotypic, localisation and in situ functional level. The application of complementary methods is a prerequisite for a comprehensive delineation of the immune landscape at the tissue level. ABSTRACT Given the role of follicular immune dynamics, especially the germinal
Spiros Georgakis   +11 more
wiley   +1 more source

Angioimmunoblastic T-Cell Lymphoma with Polyclonal Proliferation of Plasma Cells: A Cautionary Note for Flow Cytometry Interpretations

open access: yesKorean Journal of Clinical Laboratory Science, 2022
Angioimmunoblastic T-cell lymphoma (AITL) is a lymphoproliferative disorder of mature T follicular helper cells. Atypical lymphoid cells were observed in the bone marrow of an 80-year-old woman, and the flow cytometric determined immunophenotypes of B ...
Woo Yong Shin   +4 more
doaj   +1 more source

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. [PDF]

open access: yes, 2016
Angioimmunoblastic T-cell lymphoma (AITL) and other lymphomas derived from follicular T-helper cells (TFH) represent a large proportion of peripheral T-cell lymphomas (PTCLs) with poorly understood pathogenesis and unfavorable treatment results.
Bernard, Olivier   +27 more
core   +3 more sources

Diagnosis and Classification of Primary Nodal Lymphomas in Dogs: A Consensus of the Oncology‐Pathology Working Group

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT One of the primary objectives of the Oncology Pathology Working Group (OPWG) is for oncologists and pathologists to collaboratively generate consensus documents to standardise aspects of and provide guidelines for oncologic pathology in veterinary species.
Michael O. Childress   +14 more
wiley   +1 more source

Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T‐cell lymphoma: A case report

open access: yesClinical Case Reports, 2023
Key Clinical Message This case report highlights the potential of belinostat for the treatment of relapsed/refractory peripheral T‐cell lymphomas, for which effective therapies are still scarce.
Vincent Camus   +16 more
doaj   +1 more source

Diffuse Large B-cell Lymphoma in Patient after Treatment of angioimmunoblastic T-cell Lymphoma [PDF]

open access: yes, 2010
Relatively few cases of Epstein-Barr (EBV)-positive B-cell lymphomas arising in patients with angioimmunoblastic T-cell lymphoma (AITL) have been reported.
Branimir Jakšić   +5 more
core   +1 more source

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers. [PDF]

open access: yes, 2015
Immunologic checkpoint blockade with antibodies against the programmed cell death protein-1 (PD-1) or its ligand (PD-L1) is an effective method for reversing cancer immunosuppression and thereby promoting immune responses against several cancer types ...
Homet Moreno, B, Ribas, A
core   +2 more sources

Home - About - Disclaimer - Privacy